GDC-6036
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GDC-6036, covering 2026-02-12 to 2026-02-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation [Phase 1]